专题:Soft tissue tumor case studies

This cluster of papers focuses on the clinicopathologic characteristics, genetic mutations, and treatment strategies for fibrous tumors such as Solitary Fibrous Tumors and Desmoid Tumors. It discusses the identification of recurrent gene fusions, the distinction from histologic mimics, risk assessment models, and the efficacy of various treatments including surgery, radiation therapy, and targeted therapies.
最新文献
Peer Review of “Localized Immune Cascade Programming in Desmoplastic Tumors: In Silico Modeling and Validation Study”

article Full Text OpenAlex

Peer Review of “Localized Immune Cascade Programming in Desmoplastic Tumors: In Silico Modeling and Validation Study”

article Full Text OpenAlex

Localized Immune Cascade Programming in Desmoplastic Tumors: In Silico Modeling and Validation Study

article Full Text OpenAlex

Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors

article Full Text OpenAlex

Clinical features and prognosis of orbital inflammatory myofibroblastic tumor

article Full Text OpenAlex

Diagnostic potential of a novel immunohistochemical marker, GFPT2 , in differentiating mesothelioma from its morphological mimics

article Full Text OpenAlex

USP8-Rearranged Mesenchymal Tumors With Myofibroblastic Phenotype: A Comprehensive Clinicopathologic, Genetic, and Epigenetic Characterization

article Full Text OpenAlex

Case Report: Nirogacestat therapy induces rapid response in a patient with refractory, life-threatening desmoid tumor

article Full Text OpenAlex

Soft Tissue-RADS: An ACR Work-in-Progress Framework for Standardized Reporting of Soft-Tissue Lesions on MRI

article Full Text OpenAlex

TRAF7 ‐Mutated Myxoid and Spindle Cell Mesenchymal Tumor Occurring in a Pediatric Patient in the Post‐Transplant Setting: Expanding the Spectrum of TRAF7 ‐Mutated Tumors

article Full Text OpenAlex

近5年高被引文献
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors

article Full Text OpenAlex 217 FWCI54.7896

The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification

review Full Text OpenAlex 178 FWCI25.693

What do we know about inflammatory myofibroblastic tumors? – A systematic review

review Full Text OpenAlex 110 FWCI17.8777

Inflammatory Myofibroblastic Tumour: State of the Art

review Full Text OpenAlex 90 FWCI14.2942

Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis

review Full Text OpenAlex 87 FWCI18.1586

Ultrasonography of Superficial Soft-Tissue Masses: Society of Radiologists in Ultrasound Consensus Conference Statement

review Full Text OpenAlex 86 FWCI13.79

Desmoid Tumors: A Comprehensive Review

review Full Text OpenAlex 76 FWCI19.189

Evolving strategies for management of desmoid tumor

review Full Text OpenAlex 68 FWCI10.5563

Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond

review Full Text OpenAlex 66 FWCI10.7256

Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas

review Full Text OpenAlex 65 FWCI13.5499